Tight junctions and their role in cancer metastasis

Histology and Histopathology

Volumn 16, Issue 4, 2001, Pages 1183-1195

  Martin, T A ^a   Jiang, W G ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Cancer metastasis; Tight junctions

Indexed keywords

CELL ADHESION MOLECULE; CLAUDIN; OCCLUDIN; PROTEIN;

CANCER; CANCER CELL; CANCER INVASION; CELL INTERACTION; CELL MEMBRANE PERMEABILITY; CELL ULTRASTRUCTURE; DIFFUSION; ENDOTHELIUM CELL; EPITHELIUM CELL; EXPERIMENTAL MODEL; HUMAN; METASTASIS; MOLECULAR DYNAMICS; NONHUMAN; PERMEABILITY BARRIER; REVIEW; TIGHT JUNCTION; TUMOR DIFFERENTIATION; VASCULAR ENDOTHELIUM;

ANIMALS; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; TIGHT JUNCTIONS;

EID: 0034772177     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (97)

1. Characterisation of ZO-1, a protein component of the tight junction from mouse liver and Madin-Darby canine kidney cells
2. The tight junction protein ZO-1 and an interacting transcription factor regulate Er B-2 expression
3. Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein
4. Multiple domains of occludin are involved in the regulation of paracellular permeability
5. Cell adhesion molecules in angiogenesis
6. Neutrophil adhesion and transmigration induce cleavage of endothelial occludin, a transmembrane tight junction protein
7. Glucocorticoid-induced functional polarity of growth-factor responsiveness regulates tight junction dynamics in transformed mammary epithelial tumour-cells
8. Molecular physiology and pathophysiology of tight junctions - I. Biogenesis of tight junctions and epithelial polarity
9. COOH terminus of occludin is required for tight junction barrier function in early embryos
10. Tight junction protein ZO-2 is differentially expressed in normal pancreatic ducts compared to human pancreatic adenocarcinomas
11. Cingulin, a new peripheral component of tight junctions
12. Modification of tight junction function by protein kinase C isoforms
13. Protein kinase C activation leads to dephosphorylation of occludin and tight junction permeability increase in LLC-PK1 epithelial cell sheets
14. Altered gap and tight junctions in human thyroid oncocytic tumors: A study of 8 cases by freeze-fracture
15. Calcium and tight junctions
16. Cingulin contains globular and coiled-coil domains and interacts with ZO-1, ZO-2, ZO-3 and myosin
17. Molecular structure and assembly of the tight junction
18. Regulation of epithelial tight junction permeability by cyclic-AMP
19. Transmembrane proteins in the tight junction barrier
20. Fighting cancer by attacking its blood supply
21. Angiogenesis
22. Occludin - A novel integral membrane-protein localising at tight junctions
23. A single gene product claudin-1 or -2, reconstitutes tight junction strands and recruits occludin in fibroblasts
24. Leaks in the epithelial barrier caused by spontaneous and TNF-alpha-induced single-cell apoptosis
25. Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins
26. MAGUK proteins: Structure and role in the tight junction
27. Effect of hepatocyte growth factor on assembly of zonula occluden-1 protein at the plasma membrane
28. Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium
29. Molecular aspects of the metastatic cascade
30. Occludin as a possible determinant of tight junction permeability in endothelial cells
31. Loss of the tight junction MAGUK ZO-1 in breast cancer - Relationship to glandular differentiation and loss of heterozygosity
32. The 220 kDa protein colocalising with cadherins in non-epithelial cells is identical to ZO-1, a tight junction associated protein in epithelial cells: cDNA cloning and immunoelectron microscopy
33. Involvement of ZO-1 in cadherin-based cell adhesion through its direct binding to α-catenin and actin filaments
34. Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2 and ZO-3, with the COOH termini of claudins
35. The molecular and cellular basis of cancer invasion and metastasis and its implications for treatment
36. Regulation of tight junction permeability and occludin expression by polyunsaturated fatty acids
37. Essential fatty acids, molecular and cellular basis of their anticancer action
38. Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical impact in the development of cancer
39. Hepatocyte growth factor/scatter factor decreases the expression of occludin and transendothelial resistance (TER) and increases paracellular permeability in human vascular endothelial cells
40. Tight junctions, a critical structure in the control of cancer invasion and metastasis
41. Structural and functional regulation of tight junctions by RhoA and Rac1 small GTPases
42. Symplekin, a novel type of tight junction plaque protein
43. The structure of tight junctions in human thyroid tumours. A systematic freeze-fracture study
44. Expression of occludin, tight-junction-associated protein, in human digestive tract
45. Tight junctions of the blood-brain barrier
46. Genomic organization of claudin-1 and its assessment in hereditary and sporadic breast cancer
47. Growth factor-induced morphological, physiological and molecular characterisations in cerebral endothelial cells
48. 2+-independent cell-adhesion activity of claudins, a family of integral membrane proteins localised at tight junctions
49. Tight junction dynamics: Oscillations and the role of protein kinase C
50. The molecular structure of the tight junction
51. Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme
52. Expression from the human occludin promoter is affected by tumor necrosis factor alpha and interferon gamma
53. NK4, a HGF/SF antagonist, inhibits breast cancer cell invasion of endothelium: Its role in HGF/SF induced changes of tight junction function
54. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocytes transmigration
55. Biogenesis of tight junctions: The C-terminal domain of occludin mediates basolateral targeting
56. Occludin and the function of tight junctions
57. Characterization of the interaction between protein 4.1R and ZO-2 - A possible link between the tight junction and the actin cytoskeleton
58. Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands
59. Occludin 1B, a variant of the tight junction protein occludin
60. Morphology of tight junctions in the cilliary epithelium of rabbits during arachidonic acid induced breakdown of the blood aqueous barrier
61. Prostaglandin I2 and E2 have synergistic role in rescuing epithelial barrier function in porcine ileum
62. Hepatocyte growth factor/scatter factor effects on epithelia - Regulation of intercellular-junctions in transformed and nontransformed cell-lines, basolateral polarisation of c-met receptor in transformed and natural intestinal epithelial, and induction of rapid wound repair in a transformed model epithelium
63. Molecular physiology and pathophysiology of tight junctions IV. Regulation of tight junctions by extracellular stimuli: Nutrients, cytokines, and immune cells
64. Biological implications of macrophage infiltration in human tumour angiogenesis
65. Effects of basic FGF and TGF (beta 1) on F-actin and ZO-1 organization during cat endothelial wound healing
66. Tight junctions in epithelial cells of human fetal hindgut, normal colon and colon adenocarcinoma
67. The PDZ domains of zonula occludens-1 induce an epithelial to mesenchymal transition of Madin-Darby canine kidney I cells - Evidence for a role of beta-catenin/Tcf/Lef signaling
68. Possible involvement of phosphorylation of occludin in tight junction formation
69. Localisation of 7H6 tight-junction-associated antigen along the cell border of vascular endothelial cells correlates with paracellular barrier function against ions, large molecules and cancer cells
70. Differentiation of the epithelial apical junctional complex during mouse preimplantation development: A role for rab13 in the early maturation of the tight junction
71. Inhibitory effects of malotilate on in vitro invasion of lung endothelial cell monolayer by human oral squamous cell carcinoma cells
72. 2+ resorption
73. Increased tight junction permeability is associated with development of colon cancer
74. Prolactin, alone or in combination with glucocorticoids, enhances tight junction formation and expression of the tight junction protein occludin in mammary cells
75. Identification of ZO-1: A high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelial cells
76. ZO-1 and cingulin - Tight junction proteins with distinguishing identities and localisations
77. SEMP1, a senescence-associated cDNA isolated from human mammary epithelial cells, is a member of an epithelial membrane protein superfamily
78. Basement membrane proteins influence brain capillary endothelial barrier function in vitro
79. Enhanced paracellular barrier function of rat mesothelial cells partially protects against cancer cell penetration
80. Molecular dissection of tight junctions
81. Occludin and claudins in tight junction strands: Leading of supporting players?
82. Tumor-conditioned medium increases macromolecular permeability of endothelial cell monolayers
83. Occludin confers adhesiveness when expressed in fibroblasts
84. Tight junction protein ZO-1 isoforms (alpha(+) and alpha(-)) show differential extractability and epidermal-growth-factor-induced tyrosine phosphorylation in A431 cells
85. Occludin proteolysis and increased permeability in endothelial cells through tyrosine phosphatase inhibition
86. Modulation of tight junction structure and function by cytokines
87. VEGf increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly
88. Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis maps to chromosome 3q27 and is associated with mutations in the PCLN-1 gene
89. Identification and characterisation of human junctional adhesion molecule (JAM)
90. Modulation of tight junction structure in blood-brain-barrier endothelial-cells effects of tissue-culture, 2nd messengers and cocultured astrocytes
91. A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier
92. Antagonistic regulation of tight junction dynamics by glucocorticoids and transforming growth factor beta in mouse mammary epithelial cells
93. Involvement of the helix-loop-helix protein Id-1 in the glucocorticoid regulation of tight junctions in mammary epithelial cells
94. Localization of occludin, ZO-1, and pan-cadherin in rabbit ciliary epithelium and iris vascular endothelium
95. The ras target AF-6 interacts with ZO-1 and serves as a peripheral component of tight junctions in epithelial cells
96. Interferon-gamma decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin
97. Localisation of the 7H6 antigen at tight junctions correlates with the paracellular barrier function of MDCK cells